Magnetic Resonance Imaging Study on Patients With Hemifacial Spasm
Launched by FIRST AFFILIATED HOSPITAL XI'AN JIAOTONG UNIVERSITY · Nov 20, 2020
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating how advanced imaging techniques can help better understand and diagnose hemifacial spasm (HFS), a condition where one side of the face experiences involuntary muscle contractions. The researchers want to see if new methods of MRI, which create 3D images of the facial nerve and surrounding blood vessels, can provide clearer details about nerve compression caused by nearby blood vessels. They also aim to evaluate certain measurements of the facial nerve to see if they can predict how severe a patient's symptoms might be.
To be eligible for this study, participants should have been diagnosed with primary HFS, experiencing involuntary spasms on one side of their face for at least a year. People with other causes for their symptoms, such as tumors, or those with certain medical devices like pacemakers, will not be included. If you qualify and choose to participate, you can expect to undergo advanced MRI scans, which will help researchers gather important information about your condition to improve future treatment options.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Primary HFS patients according to medical history and typical facial muscle spasms that are unilateral, involuntary, and had intermittent contractions innervated by the ipsilateral facial nerve. The patient has 1 year disease duration at least.
- Exclusion Criteria:
- • Secondary causes of HFS, such as tumors or cysts compressing the facial nerve in the cerebellar pontine cistern; Precarious general health status; Percutaneous lesions or surgical treatments; Cardiac pacemaker or metal implants.
About First Affiliated Hospital Xi'an Jiaotong University
The First Affiliated Hospital of Xi'an Jiaotong University is a leading medical institution renowned for its commitment to advancing healthcare through clinical research and innovative treatment approaches. As a prominent academic hospital in China, it integrates clinical practice, education, and research, fostering a collaborative environment that enables the development of cutting-edge therapies and medical technologies. With a multidisciplinary team of experts and state-of-the-art facilities, the hospital plays a pivotal role in conducting high-quality clinical trials that aim to improve patient outcomes and contribute to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Xi'an, Shaanxi, China
Patients applied
Trial Officials
Ming Zhang, M.D. & Ph.D.
Principal Investigator
First Affiliated Hospital Xi'an Jiaotong University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials